Skip to main content
. 2016 Jun 10;14:31. doi: 10.1186/s12958-016-0164-y

Fig. 1.

Fig. 1

Study Design Showing Cycle 2 (Panel A) and Cycle 3 (Panel B) of Ovaleap® Treatment. a Ovaleap® Cycle 2. b Ovaleap® Cycle 3. d, days; hCG, human chorionic gonadotropin; V1, Visit 1; V2, Visit 2; V3, Visit 3; V4, Visit 4; W 12, Week 12. aThe duration of Ovaleap® treatment was at the discretion of the investigator